Mixture of hmos
AssigneeSociete des Produits Nestle S.A.
InventorsBruce McConnell, Louise Kristine Vigsnaes
Life of this patent
Estimating the term…
Abstract
The invention relates to a mixture of human milk oligosaccharides and composition comprising thereof, that consists essentially of: LNnT, LNT, 2′-FL, 3′-SL, 6′-SL and either DFL or 3-FL, preferably DFL, that can be useful for preventing and/or treating viral and/or bacterial infections in a human.
Claims11
A composition for infants or young children comprising a synthetic mixture of HMOs consisting essentially of LNnT, LNT, 2′-FL, 3′-SL, 6′-SL and either DFL or 3-FL.
A method for preventing and/or treating viral and/or bacterial infections in an infant or a young child;
- ii) modulating the microbiota of an infant or a young child;
- and/or iii) improving the cognitive function of an infant or a young child, comprising administering a composition comprising:
- a mixture of HMOs consisting essentially of LNnT, LNT, 2′-FL, 3′-SL, 6′-SL and either DFL or 3-FL to the infant or child.
A method of modulating the microbiota of an infant or a young child to increase the abundance of Bifidobacterium and to reduce the abundance of Ruminococcus gnavus, modulating the microbiota of an infant or a young child to increase Bifidobacterium abundance and to at least maintain the abundance of Faecalibacterium, method of preventing or treating viral and/or bacterial infections in an infant or a young child, and improving the cognitive function of an infant or a young child, particularly an infant, the method comprising:
- administering, to the infant or young child, a mixture of HMOs consisting essentially of LNnT, LNT, 2′-FL, 3′-SL, 6′-SL and either DFL or 3-FL.
11-15. (canceled)
Dependencies are inferred from the claim text.